This is a study to compare the effects of budesonide-MMX to Asacol versus a placebo in patients with ulcerative colitis. This national study is currently recruiting adults ages 18 years to 75 years old who have this condition and meet other study requirements.
Read moreLast week, the Food and Drug Administration (FDA) listened to presentations and comments from several members of an expert FDA advisory... Read more »
Last month the FDA (Food and Drug Administration) voted unanimously that the benefit of Advair and Symbicort outweighed the risks of... Read more »
Chances are if you have asthma you have some degree of chronic (it's always there) inflammation in your air passages. Studies have... Read more »
One of the first priorities of anyone new to this asthma thing is to improve our asthma wisdom. We need to know as much about this disease... Read more »
While it has not yet been approved in the United States, Symbicort may some day be available as a rescue inhaler as well as a ... Read more »
Data from a study comparing Symbicort (budesonide, formoterol), Advair (fluticasone propionate, salmeterol), and salbutamol has found that... Read more »
Chronic sinusitis--a frustrating and painful disorder that affects up to 14 percent of Americans--may be eased with a steroid nasal wash, a small... Read more »
A new study has found that using Symbicort as both a preventative asthma medicine and as a "rescue" drug cuts asthma patients' risk of having severe... Read more »
British drugmaker AstraZeneca has launched the asthma med Symbicort in the United States. Symbicort combines the corticosteroid budesonide with... Read more »
The Food and Drug Administration has approved a new combination treatment, Symbicort, for the treatment of asthma in people ages 12 and older.... Read more »